GE Healthcare Technologies Inc (GEHC) Receives a Hold from Bank of America Securities
TipRanks (Fri, 12-Jun 6:56 AM ET)
GE Healthcare Advances Portrait Mobile V2.0 Trial, Signaling Ongoing Push in Hospital Monitoring
TipRanks (Wed, 10-Jun 12:32 PM ET)
GE HealthCare advancing enterprise imaging with cloud-enabled solutions
Business Wire (Tue, 9-Jun 9:00 AM ET)
Market Chameleon (Thu, 4-Jun 5:05 AM ET)
Business Wire (Thu, 4-Jun 8:00 AM ET)
Business Wire (Mon, 1-Jun 8:10 AM ET)
Business Wire (Fri, 22-May 5:00 PM ET)
Business Wire (Fri, 22-May 3:00 PM ET)
Business Wire (Fri, 22-May 1:22 PM ET)
Globe Newswire (Thu, 21-May 7:00 PM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of June 15, 2026, GEHC stock price declined to $64.76 with 2,988,320 million shares trading.
GEHC has a beta of 1.31, meaning it tends to be more sensitive to market movements. GEHC has a correlation of 0.23 to the broad based SPY ETF.
GEHC has a market cap of $29.46 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $5 billion in Revenue and $.99 earnings per share. This beat revenue expectation by $99 million and missed earnings estimates by -$.06.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a return of -11.2%, while the SPY ETF gained +26.2%. In the last 3 month period, GEHC fell short of the market, returning -7.9%, while SPY returned +13.6%. However, in the most recent 2 weeks GEHC has outperformed the stock market by returning +3.9%, while SPY returned -0.2%.
GEHC support price is $63.93 and resistance is $66.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.
